Randomized Trial of Single Agent Paclitaxel Given Weekly Versus Every Three Weeks and with Peroral Versus Intravenous Steroid Premedication to Patients with Ovarian Cancer Previously Treated with Platinum

By Rosenberg Per   Andersson Ha˚kan   Boman Karin   Ridderheim Mona   Sorbe Bengt   Puistola Ulla   Parö Gunnar  

Acta Oncologica, Vol. 41, Iss. 5, 2002-09 ,pp. : 418-424

Informa Healthcare

Access to resources Recommend Favorite

A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 281-286

Science Publishers

Access to resources Recommend Favorite

Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial

By Courneya Kerry   Segal Roanne   Mackey John   Gelmon Karen   Friedenreich Christine   Yasui Yutaka   Reid Robert   Jespersen Diana   Cook Diane   Proulx Carolyn   Trinh Linda   Dolan Lianne   Wooding Evyanne   Forbes Cynthia   McKenzie Donald  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 361-369

Springer Publishing Company

Access to resources Recommend Favorite

Quality of Life in Ovarian Cancer Patients Receiving Chemotherapy

By Lakusta C.M.   Atkinson M.J.   Robinson J.W.   Nation J.   Taenzer P.A.   Campo M.G.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 490-495

Elsevier

Access to resources Recommend Favorite

Ovarian Histopathology in Breast Cancer Patients Receiving Tamoxifen

By McGonigle K.F.   Vasilev S.A.   Odom-Maryon T.   Simpson J.F.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 402-406

Elsevier

Access to resources Recommend Favorite